Works matching IS 01986325 AND DT 2019 AND VI 39 AND IP 4
Results: 9
Dual DNA topoisomerase 1 and tyrosyl‐DNA phosphodiesterase 1 inhibition for improved anticancer activity.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1427, doi. 10.1002/med.21587
- By:
- Publication type:
- Article
Editorial page, special issue honoring Professor Mark Cushman.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
A review of the molecular design and biological activities of RXR agonists.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1372, doi. 10.1002/med.21578
- By:
- Publication type:
- Article
Understanding the riboflavin biosynthesis pathway for the development of antimicrobial agents.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1338, doi. 10.1002/med.21576
- By:
- Publication type:
- Article
Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1398, doi. 10.1002/med.21568
- By:
- Publication type:
- Article
Topoisomerase 1B poisons: Over a half‐century of drug leads, clinical candidates, and serendipitous discoveries.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1294, doi. 10.1002/med.21546
- By:
- Publication type:
- Article
Challenges and approaches in the discovery of human immunodeficiency virus type‐1 non‐nucleoside reverse transcriptase inhibitors.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1235, doi. 10.1002/med.21544
- By:
- Publication type:
- Article
Polyphenolic natural products and natural product–inspired steroidal mimics as aromatase inhibitors.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1274, doi. 10.1002/med.21536
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1229, doi. 10.1002/med.21524
- Publication type:
- Article